Trends in the use of perioperative chemotherapy for localized and locally advanced muscle-invasive bladder cancer: a sign of changing tides.
about
Risk based neoadjuvant chemotherapy in muscle invasive bladder cancerSystemic, perioperative management of muscle-invasive bladder cancer and future horizons.Systemic therapy for bladder cancer finally comes into a new age.A nomogram predicting the cancer-specific mortality in patients eligible for radical cystectomy evaluating clinical data and neoadjuvant cisplatinum-based chemotherapy.Advances in surgical management of muscle invasive bladder cancer.Systemic therapy in bladder cancerTreatment of muscle-invasive bladder cancer in Canada: A survey of genitourinary medical oncologists and urologists.Predictors of referral for neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer and changes in practice over timeRe: The feasibility of radical cystectomy in elderly patients.High rates of venous thromboembolic events in patients undergoing systemic therapy for urothelial carcinoma: A systematic review and meta-analysis.The initiation of a multidisciplinary bladder cancer clinic and the uptake of neoadjuvant chemotherapy: A time-series analysis.Perioperative chemotherapy for muscle-invasive bladder cancer: Closing the gap between evidence and practiceMulticenter assessment of neoadjuvant chemotherapy for muscle-invasive bladder cancer.Effect of Neoadjuvant Chemotherapy on Renal Function following Radical Cystectomy: Is there a Meaningful Impact?Bladder cancer in 2015: Improving indication, technique and outcome of radical cystectomy.A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naïve Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, anNeoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis.Contemporary update on neoadjuvant therapy for bladder cancer.The Cancer of the Bladder Risk Assessment (COBRA) score: Estimating mortality after radical cystectomy.Use of Adjuvant Chemotherapy in Patients with Advanced Bladder Cancer after Neoadjuvant Chemotherapy.Trends in neoadjuvant chemotherapy use and oncological outcomes for muscle-invasive bladder cancer in Japan: a multicenter study.Impact of preoperative diagnostic TURBT on progression-free survival in patients with pathological high-grade, stage T3/T4 bladder urothelial carcinoma.Perioperative chemotherapy for bladder cancer: A qualitative study of physician knowledge, attitudes, and behaviour.Peri-Operative Chemotherapy for Bladder Cancer: A Survey of Providers to Determine Barriers and Enablers.Peri-operative chemotherapy for muscle-invasive bladder cancer: status-quo in 2017.Epidemiology and Hospitalization Cost of Bladder Cancer in Kerman Province, Southeastern Iran.B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patients.Sarcopenia as a comorbidity-independent predictor of survival following radical cystectomy for bladder cancer.Refining the use of neoadjuvant chemotherapy in locally advanced bladder cancer: from conviction to optimization
P2860
Q26773664-75C8C1DA-DBDA-42B0-8D87-3D4B1C922FB5Q30240816-03212354-0722-489D-9C8D-C2E915CA74B5Q30249047-AD1B181E-2BA3-406F-A094-4252DFE506BEQ30981992-3607AE5A-8FDA-4047-A18E-C99E384B9205Q33578553-186B6E0D-857D-4140-A698-D77BB769D283Q33578564-3353FF76-807F-45C4-8F5E-9CDE6BC13F69Q34435978-B865049E-8243-47EF-9170-E93314D7DA47Q35956231-FF7168D3-3C5F-445F-94CF-3F0DBE64BD80Q35993984-F5700455-5C84-406C-AA35-4C88CFF3CE26Q36042344-22203BB2-A1DB-41B5-B498-977BA4AEBCF7Q36631959-F90EF435-D8CC-475A-945E-0BC0D0C0988FQ36631963-A337DA44-FDD3-40C5-A9E7-14B5CB9CD425Q36823607-6E35E68B-BE9F-49BD-9D9D-29B1A2BD7492Q37530344-16DAB903-77C4-4991-B06F-769005054DCBQ38644602-2B43799F-F216-48EC-8238-BBC3394ACC4CQ38732403-31B9A10A-B5A6-4E25-A16D-D32D2CC2FE86Q38800274-74A77473-8993-4282-B51E-6449345C5477Q39177293-B82BBEA1-A1DC-4596-9E2F-0F3138E38FEDQ40053390-FE740808-AF72-4891-A4CF-0EF76E083C63Q41273398-C37149C7-EBC4-4C18-875B-76400A44C38DQ44761739-C816ECC3-DEC5-4F06-8B35-B918B65CDD10Q47110089-E5CB8335-3F04-4D8C-88BB-498EA8975230Q47562271-DA2A7650-F4B3-43C2-B987-5157FC4190D7Q49398793-E31BAB80-31D4-43F4-A128-850DA641D03AQ49526759-915804F3-8026-4665-9C69-7613BAA4C230Q55053860-5798A089-B32E-41CB-B527-036C64CB75BDQ55110736-5E190347-8289-4EDC-BC32-9642ED35724EQ55343308-7549DA6E-DD95-49A9-9A34-731031198CD7Q58804615-2E2F44EC-A5C1-40E2-B15F-2B129D71712D
P2860
Trends in the use of perioperative chemotherapy for localized and locally advanced muscle-invasive bladder cancer: a sign of changing tides.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Trends in the use of periopera ...... cer: a sign of changing tides.
@ast
Trends in the use of periopera ...... cer: a sign of changing tides.
@en
type
label
Trends in the use of periopera ...... cer: a sign of changing tides.
@ast
Trends in the use of periopera ...... cer: a sign of changing tides.
@en
prefLabel
Trends in the use of periopera ...... cer: a sign of changing tides.
@ast
Trends in the use of periopera ...... cer: a sign of changing tides.
@en
P2093
P2860
P1433
P1476
Trends in the use of periopera ...... cer: a sign of changing tides.
@en
P2093
C J Stimson
Daniel A Barocas
Harras B Zaid
Kirk A Keegan
Matthew J Resnick
Michael S Cookson
Sam S Chang
Sanjay G Patel
Zachary D Reardon
P2860
P304
P356
10.1016/J.EURURO.2014.01.009
P407
P577
2014-01-23T00:00:00Z